跳至主要内容
临床试验/NCT02700711
NCT02700711已完成1 期

Randomized Clinical Trial: 03 (Methylphenidate and Duloxetine)

University of Kentucky1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
13
试验地点
1
主要终点
Number of Cocaine Positive Urines

研究概览

简要总结

This study will determine the influence of methylphenidate (e.g., Ritalin®) and duloxetine (Cymbalta®), alone and in combination, on the cocaine use as measured by self-report and urine drug screens.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Recent cocaine use
  • Seeking treatment for cocaine use

排除标准

  • Abnormal screening outcome (e.g., ECG, blood chemistry result) that study physicians deem clinically significant
  • Current or past histories of substance abuse or dependence that are deemed by the study physicians to interfere with study completion
  • History of serious physical disease or current unstable physical disease (e.g., past myocardial infarction, uncontrolled hypertension, diabetes, head trauma, seizures or CNS tumors) or current or past histories of serious psychiatric disorder or suicidal risk, other than substance abuse or dependence, will be excluded from research participation
  • Females not currently using effective birth control
  • Contraindications to cocaine, methylphenidate or duloxetine
  • Currently using opioids for pain or who are currently maintained on methadone or buprenorphine for opioid use disorder will be excluded from participation
  • Body weight less than 50 kg

研究组 & 干预措施

Placebo

Placebo Comparator

Subjects will be maintained on oral placebo. Subjects will be maintained on placebo and methylphenidate during placebo maintenance.

干预措施: Methylphenidate (Drug)

Placebo

Placebo Comparator

Subjects will be maintained on oral placebo. Subjects will be maintained on placebo and methylphenidate during placebo maintenance.

干预措施: Placebo (Drug)

Duloxetine

Experimental

Subjects will be maintained on oral duloxetine. Subjects will be maintained on placebo and methylphenidate during duloxetine maintenance.

干预措施: Methylphenidate (Drug)

Duloxetine

Experimental

Subjects will be maintained on oral duloxetine. Subjects will be maintained on placebo and methylphenidate during duloxetine maintenance.

干预措施: Placebo (Drug)

Duloxetine

Experimental

Subjects will be maintained on oral duloxetine. Subjects will be maintained on placebo and methylphenidate during duloxetine maintenance.

干预措施: Duloxetine (Drug)

结局指标

主要结局

Number of Cocaine Positive Urines

时间窗: Six weeks

Cocaine use will be assessed using qualitative urine drug screens over a six week period.

次要结局

  • Self-Reported Cocaine Use(Six weeks)
  • Blood Pressure(Six weeks)
  • Heart Rate(Six weeks)
  • Side effects(Six weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Craig Rush

Professor

University of Kentucky

研究点 (1)

Loading locations...

相似试验